Company Overview

Management Philosophy of SBI Pharmaceuticals

1. Maintain high medical ethics, as represented by our mission to provide accessible medical care for mankind and enforce this principle through full regulatory compliance in each country where we carry out activities.


2. Become an innovator in the fields of pharmaceutical, health food production, cosmetics, livestock feeds, and fertilizers, and contribute to the advancement of the health and well-being of people through the provision of safe health products and the efficient production of safe food.


3. Develop an organization that flexibly adapts to changes in the operating environment and continue to self-evolve as a corporation that fuses ingenuity and a self-innovating spirit.


4. Recognize our social responsibility as a member of society in each country where we carry out operations and contribute to the advancement of that society, while meeting the demands of various stakeholders

Company Overview

Name

SBI Pharmaceuticals Co., Ltd.

Business

R&D, manufacture and marketing of the medicines, medical devices, cosmetics and health foods that utilize 5-ALA (5-aminolevulinic acid)

Address

(Headquarters) Izumi Garden Tower 20F, 1-6-1, Roppongi, Minato-ku, Tokyo 106-6020, Japan, Direct link with Roppongi 1-chome Station,

(Research Institute) Innovation Center of NanoMedicine (iCONM) 4F, 3-25-14 Tono-machi, Kawasaki-ku
Kawasaki-shi, Kanagawa 210-0821, Japan, 15 minute-walk from Kojimashinden Station.

TEL

(Headquarters) Tel: 03-6229-0095; Fax: 03-3589-0761

(Research Institute) Tel: 044-382-0500; Fax: 044-382-0510

Date Founded

April 18, 2008

Main Shareholder

SBI ALApharma Co., Ltd.

Capital

100 Million Yen

Directors

Representative Director, President                                               Yoshitaka Kitao
Representative Director, Senior Executive Vice President  Ulrich Kosciessa
Director, Executive Officer CFO                                                       Kenji Hirai
Director, Executive Officer                                                                Motowo Nakajima
Director, Executive Officer COO                                                      Masahiro Takeoka
Director, Executive Officer                                                                Masahiro Ishizuka
Director                                                                                                     Yasushi Takezaki
Statutory Auditor                                                                                 Hideyuki Katsuchi

Corporate History

2008 April

SBI ALApromo (former SBI Pharmaceuticals) established.
2011

July
Laboratory transferred from Setagaya to Kobe

2012

April
Name changed to SBI Pharmaceuticals.
Cosmetic and health food business transferred to newly established company named SBI ALApromo.
Agreement reached with the Bahrein government to proceed with our 5 ALA business.

 

2013

September
Sale launched of ALAGLIO® Internal Medicine 1.5 g as a Photodynamic diagnostic agent for brain cancer

2014

April
Sale launched of medical light source Bicolor LED Light Source Aladuck LS-DLED

 

2017

January
Received the Minister of Economy, Trade and Industry Award at the Japan Bio-venture Awards.

February
Received the Seiichi Tejima Invention Award

December
Sale launched of ALAGLIO® Divided Granules 1.5 g as a photodynamic diagnostic agent for bladder cancer.

2018

March
Laboratory transferred from Kobe to Kawasaki.

Now

About Us

Our Strengths

Mechanical Translations by Google »